CXCL13 and myeloid sarcoma: –Higher CHI3L1 and CXCL13 in MS vs. control–Lower CCL2, BAFF, and APRIL in RMS vs. others–High CSF biomarkers (CHI3L1, CXCL10, CXCL12, and CXCL13) are associated with CDMS risk